Matthew Ferguson - Mar 8, 2023 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for Matthew Ferguson
Stock symbol
ELUT
Transactions as of
Mar 8, 2023
Transactions value $
$0
Form type
4
Date filed
3/9/2023, 08:11 PM
Previous filing
Dec 5, 2022
Next filing
Sep 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELUT Class A Common Stock Options Exercise $0 +1.29K +2.85% $0.00 46.5K Mar 8, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELUT Restricted Stock Units Options Exercise $0 -1.29K -33.32% $0.00 2.58K Mar 8, 2023 Class A Common Stock 1.29K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
F2 On March 8, 2021, the Reporting Person was granted 5,150 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022.